In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Elevance Health Inc. trades significantly below its PERT-weighted fair value ($388.50 vs. $752.89), indicating substantial upside potential with high confidence and low downside risk. Monte Carlo analysis shows wide valuation dispersion but a median far above the current price, despite modest growth and fair financial health scores. Elevated volatility (84.34% coefficient of variation) highlights investment risk linked to assumptions on WACC and growth rates.